Essiac

Last updated

Essiac
Alternative medicine
ClaimsTreatment of cancer and other illnesses.
Related fields Alternative medicine
Year proposedapprox 1920
Original proponentsRene Caisse
Subsequent proponentsEssiac Products Inc.
MeSH C111756
See also List of questionable cancer treatments

Essiac is a herbal tea promoted as an alternative treatment for cancer and other illnesses. [1] There is no evidence it is beneficial to health. In a number of studies Essiac either showed no action against cancer cells, [2] [3] [4] or actually increased the rate of cancer growth. [5]

Contents

Background

While the formulations can vary, most Essiac formulations contain burdock root, turkey rhubarb root, sheep sorrel and slippery elm. [3] From the 1920s through the 1970s, Essiac was promoted as a cancer treatment by Rene Caisse, a Canadian nurse who invented the formula. Caisse claimed at some times that the formula had been given to her by an Ontario Ojibwa patient she treated, [2] [3] and at other times that she had learned the formula from an unnamed "medicine man". [6] Neither story has ever been substantiated. There is no evidence that Essiac is a Native American or First Nations remedy. [7] However, there are multiple factors that indicate the formula is not from any Native American or First Nations culture. Notably, in the original recipe, only one of the plants in the mixture, slippery elm, is indigenous to the Americas; none of the other herbs are native to North America. [6] [7] Caisse changed her story about the origins of the remedy, as well as the ingredients in the formula, several times, and was said to be fond of cultivating "an air of mystery" around it. [6] The name "Essiac", which Caisse gave to the tea, is Caisse's name spelled backwards. Today, Essiac is often sold with apparatus (such as bottles and infusers) for making the tea, and is sometimes promoted with untrue claims that scientific studies have shown it to be effective. [4]

In 1977, Caisse sold her Essiac formula and trademark rights to Respirin Corporation (a Canadian company and predecessor in title to Essiac Products Inc.), which attempted to commercialize the product. However, the company was unable to show any efficacy of Essiac against cancer. Repeated laboratory tests showed that Essiac failed to slow tumor growth and, in large doses, killed test animals. In a number of studies, Essiac actually increased the rate of cancer growth. [5] As a result, both the U.S. and Canadian governments refused to approve Essiac as a medical treatment. Essiac was instead marketed by Essiac Products Inc. and others as a dietary supplement, subject to much looser regulation and not required to show any proof of effectiveness. [3]

Effectiveness

Essiac's purported effect on cancer has been reviewed by several major medical and scientific bodies, including the U.S. Food and Drug Administration (FDA), [8] the National Cancer Institute, [3] and the American Cancer Society. [2] The American Cancer Society states that "Reviews of medical records of people who have been treated with Essiac do not support claims that this product helps people with cancer live longer or that it relieves their symptoms." [2] The NCI states "Essiac and Flor Essence have not reported clear evidence of an anticancer effect", [3] and the FDA described Essiac as a "Fake Cancer 'Cure' Consumers Should Avoid". [8] Researchers at Memorial Sloan-Kettering Cancer Center have written that Essiac continues to be a popular cancer therapy despite unsubstantiated claims of its effectiveness. [9] Cancer Research UK also notes that there is "no scientific evidence that Essiac can help to treat cancer" and cautions "Always ask your doctors and nurses about whether any complementary or alternative cancer therapy you are thinking of using might interact with your other treatments." [4]

Side effects

"Essiac may cause headache, nausea, diarrhea or constipation, vomiting, low blood sugar, liver damage, and kidney damage. Allergic rashes are possible. Rarely, serious allergic reactions have been reported." [2]

See also

Related Research Articles

<span class="mw-page-title-main">Constipation</span> Bowel dysfunction

Constipation is a bowel dysfunction that makes bowel movements infrequent or hard to pass. The stool is often hard and dry. Other symptoms may include abdominal pain, bloating, and feeling as if one has not completely passed the bowel movement. Complications from constipation may include hemorrhoids, anal fissure or fecal impaction. The normal frequency of bowel movements in adults is between three per day and three per week. Babies often have three to four bowel movements per day while young children typically have two to three per day.

<span class="mw-page-title-main">Ozone therapy</span> Unproven alternative medicine

Ozone therapy is an alternative medical treatment that introduces ozone or ozonides to the body. The United States Food and Drug Administration (FDA) prohibits all medical uses of ozone "in any medical condition for which there is no proof of safety and effectiveness", stating "ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy. In order for ozone to be effective as a germicide, it must be present in a concentration far greater than that which can be safely tolerated by man and animals."

<span class="mw-page-title-main">Tea tree oil</span> Essential oil derived from leaves

Tea tree oil, also known as melaleuca oil, is an essential oil with a fresh, camphoraceous odor and a colour that ranges from pale yellow to nearly colourless and clear. It is derived from the leaves of the tea tree, Melaleuca alternifolia, native to southeast Queensland and the northeast coast of New South Wales, Australia. The oil comprises many constituent chemicals, and its composition changes if it is exposed to air and oxidizes. Commercial use of tea tree oil began in the 1920s, pioneered by the entrepreneur Arthur Penfold.

<span class="mw-page-title-main">Travelers' diarrhea</span> Stomach and intestinal infection

Travelers' diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool while traveling. It may be accompanied by abdominal cramps, nausea, fever, headache and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within three to four days with little or no treatment. About 12% of people may have symptoms for a week.

<span class="mw-page-title-main">Chromotherapy</span> Alternative medicine method also known as color therapy

Chromotherapy, sometimes called color therapy, colorology or cromatherapy, is an alternative medicine that is considered pseudoscience and quackery. Chromotherapists claim to be able to use light in the form of color to balance "energy" lacking from a person's body, whether it be on physical, emotional, spiritual, or mental levels. For example, they thought that shining a colored light on a person would cure constipation. Historically chromotherapy has been associated with mysticism and occultism.

<span class="mw-page-title-main">Max Gerson</span> American physician

Max Gerson was a German-born American physician who developed the Gerson Therapy, a dietary-based alternative cancer treatment that he claimed could cure cancer and most chronic, degenerative diseases.

<span class="mw-page-title-main">Carboplatin</span> Medication used to treat cancer

Carboplatin, sold under the brand name Paraplatin among others, is a chemotherapy medication used to treat a number of forms of cancer. This includes ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma. It is used by injection into a vein.

Maalox was a brand of antacid owned by Sanofi. Their main product is a flavored liquid containing a suspension of aluminum hydroxide and magnesium hydroxide, which act to neutralize or reduce stomach acid, for the purpose of relieving the symptoms of indigestion, heartburn, gastroesophageal reflux disease, and also stomach or duodenal ulcers. It also contains simethicone, an anti-foaming agent which helps eliminate bloating from gas. In large doses, the medicine can act as a laxative. The trademark is owned by Novartis International AG, and was first produced commercially in 1949.

<span class="mw-page-title-main">Piperacillin/tazobactam</span> Combination antibiotic medication

Piperacillin/tazobactam, sold under the brand name Tazocin among others, is a combination medication containing the antibiotic piperacillin and the β-lactamase inhibitor tazobactam. The combination has activity against many Gram-positive and Gram-negative bacteria including Pseudomonas aeruginosa. It is used to treat pelvic inflammatory disease, intra-abdominal infection, pneumonia, cellulitis, and sepsis. It is given by injection into a vein.

<span class="mw-page-title-main">Rifaximin</span> Antibiotic medication

Rifaximin, is a non-absorbable, broad spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in over more than 30 countries for the treatment of a variety of gastrointestinal diseases like irritable bowel syndrome, and hepatic encephalopathy. It acts by inhibiting RNA synthesis in susceptible bacteria by binding to the RNA polymerase enzyme. This binding blocks translocation, which stops transcription. It is marketed under the brand name Xifaxan by Salix Pharmaceuticals.

Hoxsey Therapy or Hoxsey Method is an alternative medical treatment promoted as a cure for cancer. The treatment consists of a caustic herbal paste for external cancers or a herbal mixture for "internal" cancers, combined with laxatives, douches, vitamin supplements, and dietary changes. Reviews by major medical bodies, including the U.S. Food and Drug Administration (FDA), the National Cancer Institute, the American Cancer Society, M. D. Anderson Cancer Center, and Memorial Sloan-Kettering Cancer Center, have found no evidence that Hoxsey Therapy is an effective treatment for cancer. The sale or marketing of the Hoxsey Method was banned in the United States by the FDA on September 21, 1960 as a "worthless and discredited" remedy and a form of quackery.

<span class="mw-page-title-main">Alternative cancer treatments</span> Alternative or complementary treatments for cancer that have not demonstrated efficacy

Alternative cancer treatment describes any cancer treatment or practice that is not part of the conventional standard of cancer care. These include special diets and exercises, chemicals, herbs, devices, and manual procedures. Most alternative cancer treatments do not have high-quality evidence supporting their use and many have been described as fundamentally pseudoscientific. Concerns have been raised about the safety of some purported treatments and some have been found unsafe in clinical trials. Despite this, many untested and disproven treatments are used around the world.

<span class="mw-page-title-main">Lubiprostone</span> Medication used for constipation

Lubiprostone, sold under the brand name Amitiza among others, is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. The drug is owned by Mallinckrodt and is marketed by Takeda Pharmaceutical Company.

<span class="mw-page-title-main">Pertuzumab</span> Pharmaceutical drug

Pertuzumab, sold under the brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.

<span class="mw-page-title-main">Neratinib</span> Chemical compound

Neratinib (INN), sold under the brand name Nerlynx, is a tyrosine kinase inhibitor anti-cancer medication used for the treatment of breast cancer.

<span class="mw-page-title-main">Aromatherapy</span> Pseudoscientific alternative medicine practice

Aromatherapy is a practice based on the use of aromatic materials, including essential oils and other aroma compounds, with claims for improving psychological well-being. It is used as a complementary therapy or as a form of alternative medicine, and typically is used via inhalation and not by ingestion.

<span class="mw-page-title-main">Ribociclib</span> Chemical compound

Ribociclib, sold under the brand name Kisqali, is a medication used for the treatment of certain kinds of breast cancer. Ribociclib is a kinase inhibitor. It was developed by Novartis and Astex Pharmaceuticals.

<span class="mw-page-title-main">Ripretinib</span> Chemical compound

Ripretinib, sold under the brand name Qinlock, is a medication for the treatment of adults with advanced gastrointestinal stromal tumor (GIST), a type of tumor that originates in the gastrointestinal tract. It is taken by mouth. Ripretinib inhibits the activity of the kinases KIT and PDGFRA, which helps keep cancer cells from growing.

Tabelecleucel, sold under the brand name Ebvallo, is a medication used for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease. Tabelecleucel is an allogeneic, EBV-specific T-cell immunotherapy which targets and eliminates EBV-infected cells in a human leukocyte antigen (HLA)-restricted manner. It is made of cells of the immune system called T-cells that have been taken from the recipient (allogeneic) and are then mixed with EBV-infected B-cells from the same donor.

References

  1. Barrett, Stephen (July 27, 2010). "Questionable Cancer Therapies: Essiac". Quackwatch . Retrieved July 5, 2011.
  2. 1 2 3 4 5 Russell J, Rovere A, eds. (2009). "Essiac Tea". American Cancer Society Complete Guide to Complementary and Alternative Cancer Therapies (2nd ed.). American Cancer Society. pp.  342–345. ISBN   9780944235713. There have been no published clinical trials in conventional medical journals showing that either Essiac tea or Flor Essence helps in the treatment of cancer ... most laboratory studies of Essiac have found it didn't work against cancer cells, and one reported that Flor Essence increased the growth of breast cancer cells. Available scientific evidence does not support its use for the treatment of cancer in humans. ... Serious side effects are uncommon. Essiac may cause headache, nausea, diarrhea or constipation, vomiting, low blood sugar, liver damage, and kidney damage. Allergic rashes are possible. Rarely, serious allergic reactions have been reported."
  3. 1 2 3 4 5 6 "Patient Information: Essiac/Flor Essence". National Cancer Institute. July 21, 2010. Retrieved July 5, 2011.
  4. 1 2 3 "Essiac". Cancer Research UK. 30 January 2015.
  5. 1 2 "Questions and Answers About Essiac and Flor Essence". National Cancer Institute. February 19, 2013. Retrieved May 6, 2013.
  6. 1 2 3 Ellis, Christine D (2013). "Essiac Tea". Basic Herbalist Certification Course. Lulu.com. pp. 39–47. ISBN   9781300609094.
  7. 1 2 Smith, Huron H. 1932. Ethnobotany of the Ojibwe Indians. Bulletin of the Public Museum of Milwaukee 4:327-525 (p. 361). Slippery Elm is listed; Burdock is mentioned as a plant that is in use "among white men." No mention of the other ingredients in Essiac, Essiac itself, or an Essiac-like formula.
  8. 1 2 "187 Fake Cancer "Cures" Consumers Should Avoid". Guidance, Compliance & Regulatory Information. USFDA. Archived from the original on 22 March 2017.
  9. "Essiac". Memorial Sloan-Kettering Cancer Center. March 10, 2011. Retrieved December 15, 2012.

Further reading